← Upcoming Courses

In-depth ONTARGET Review - Optimizing Hypertension Management

PROUDLY SPONSORED BY

IN COLLABORATION WITH

 

This is a virtual event that will take place on Wednesday the 19th of April 2023 at 4:00 pm. The event will be streamed live on this page.

 

Target Audience: Specialists, Family Physicians, General Practitioners, and Physician Assistants

Moderator: Dr. Becky Amponsaa Appiah (Clinical Coordinator, IMAH)

Time: 1600 GMT (4:00 pm local time)

 

AGENDA

Wednesday 19th April 2023 (VIRTUAL EVENT) 

3:50 - 4:00 pm: Welcome

4:00 - 4:10 pm: Meeting Opening and Introduction by Dr. Becky Amponsaa Appiah

4:10 - 4:55 pm: CARDIOVASCULAR UPDATE - In-depth ONTARGET Review; Optimizing Hypertensive Management. by Dr. Dr. Aba Folson

4:55 - 5:10 pm: Micardis / Twynsta Dosing and Availability by Pharm. Stephen Colly (Boehringer Ingelheim Representative)

5:10 - 5:25 pm: Question and Answer Session All

4:25 - 5:30 pm: Conclusion Dr. Becky Amponsaa Appiah

Overview

Course Description

This Boehringer Ingelheim – International Maritime Hospital cardiovascular update engagement is designed to review the ONTARGET TRIAL, which sought to determine whether Telmisartan was non-inferior to Ramipril, and whether a combination of the two drugs was superior to Ramipril alone as a treatment to prevent vascular events in high-risk patients who had cardiovascular disease or Diabetes Mellitus.

The course seeks to educate participants on the results of the trial and guideline recommendations on the role of Telmisartan in providing cardiovascular protection and prevention in Hypertensives with Added-Risk. Thus, outlining the unique benefits of Telmisartan in providing powerful BP reduction and Organ protection beyond just BP lowering.

What you will learn

At the end of the review, participants are expected to;
1. become familiar with the relationship between hypertension and its complications is a continuum
2. get clarity on the classification of office blood pressure and definitions of hypertension grade
3. understand the morning surge as a therapeutic target
4. understand why Telmisartan has superior efficacy in the early morning hours


Lecture Sessions

  • LIVE EVENT: Wednesday 19th April 2023 @ 1600 GMT (4:00 pm) 1 hour 30 minutes

Downloadables

No downloadable content added to this course yet.

About Facilitator

  • 5 Courses on CES

Dr Aba Folson

BSc, MBChB, FWACP, FGCP, PGDip (Prev. Cardiol), PGCert (Interv. Cardiol)

Senior Lecturer and Consultant Cardiologist

University of Health and Allied Sciences, Greater Accra Regional Hospital

Dr. Aba Ankomaba Folson graduated from the University of Ghana Medical School, Accra, with a bachelor’s degree in Medicine (MB. CHB). She is a Fellow in Cardiology of the West African College of Physicians (FWACP).

View full profile / courses